Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.170
+0.020 (0.93%)
Apr 1, 2026, 9:30 AM EDT - Market open
Alector Market Cap
Alector has a market cap or net worth of $239.49 million as of April 1, 2026. Its market cap has increased by 75.14% in one year.
Market Cap
239.49M
Enterprise Value
17.49M
1-Year Change
75.14%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $239.49M, a decrease of -80.54%. That is a compound annual growth rate of -20.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 237.28M | 39.35% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 248.71M |
| Silence Therapeutics | 247.98M |
| Editas Medicine | 241.74M |
| Context Therapeutics | 240.72M |
| Cybin | 240.17M |
| Cellectis | 237.28M |
| Eledon Pharmaceuticals | 233.98M |
| Akari Therapeutics, | 233.13M |